StoneX Group’s Allergan plc AGN Stock Holding History

StoneX Group’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,688	Closed	-$1.63M	–	380
2017 Q2	$1.63M	Buy	+6,688	New	+$1.57M	0.51%	53

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

StoneX Group's AGN Position: Q3 2017 in Review

StoneX Group sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 6,688 shares — an estimated $1.63M sold.

StoneX Group first reported a position in AGN in Q2 2017 and held it in 1 quarter. The position peaked at $1.63M in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

StoneX Group reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
StoneX Group sold 6,688 Allergan plc shares in Q3 2017, an estimated $1.63M.
StoneX Group first reported a position in Allergan plc in Q2 2017 and held it in 1 quarter.
StoneX Group's Allergan plc position peaked at $1.63M in Q2 2017.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on StoneX Group's 13F filing for Q3 2017, filed 13 Nov 2017.